Y-Biologics develops new drugs through optimized partnerships
by having open business models based on two platform technologies (Ymax®-ABL & ALiCE).
Our strategy is to conduct joint development and investment through strategic alliances and
provide various collaboration opportunities such as CRO, joint ventures for global partnering.
- Research Collaboration